跳至主要内容
临床试验/NCT01992978
NCT01992978Unknown不适用

The Influence of Radiofrequency-assisted Hepatectomy on the Perioperative Outcomes and the Long-term Prognosis of HCC With Cirrhosis:A Prospective Randomized Controlled Trial

Southwest Hospital, China1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2013年11月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
200
试验地点
1
主要终点
Postoperative liver injury

研究概览

简要总结

Surgical resection is the most effective treatment of primary and secondary liver tumors. Technical innovations have mainly focused on minimizing bleeding during transection of the hepatic parenchyma because excessive hemorrhage and the need for blood transfusion are associated with increased postoperative morbidity and mortality. Recently,radiofrequency-assisted(RFA)hepatectomy has developed rapidly and gained widespread acceptance for the treatment of hepatocellular carcinomas(HCC),but its influence on the prognosis of HCC patients,especially for those with cirrhosis,is still controversial. Therefore, we design this prospective clinical trial to explore the effect of RFA hepatectomy versus the conventional hepatectomy on the outcomes of perioperative period and prognosis of HCC patients with cirrhosis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged from 18 to 65 years , no gender restriction.
  • Clinical diagnosis of resectable HCC.
  • Preoperative liver function test showed Child-Pugh Class A or B.
  • Indocyanine green retention at 15 minutes (ICG-15) of <30%.
  • Acceptable clotting profile :platelet count > 50 x 109/L and a prolonged prothrombin time of < 5 seconds.
  • Enough relative residual liver volume (%RLV) ≥ 40%.
  • No tumor invasion in primary branch of portal vein, hepatic vein, or inferior vena cava.
  • No other anti-tumor therapy received before the treatment.
  • No metastasis in lymphnode or other organs.
  • Written consent inform assigned.

排除标准

  • Pregnancy.
  • Intraoperative findings of tumor rupture,extrahepatic tumor or lymphnode metastasis.
  • Tumor invasion in primary branch of portal vein, hepatic vein, or inferior vena cava.

结局指标

主要结局

Postoperative liver injury

时间窗: postoperative 90 days

The degree of postoperative hepatic injury is assessed by daily measurements of postoperative aminotransferase (AST) and alanine aminotransferase (ALT) levels, serum bilirubin levels, and prothrombin times. Each patient is followed up within postoperative 90 days.

次要结局

  • Number of Participants with Adverse Events(postoperative 90 days)
  • Overall survival(1,3,5-year overall survival)

研究者

发起方
Southwest Hospital, China
申办方类型
Other
责任方
Principal Investigator
主要研究者

Li Xiaowu,MD

Dr.Xiaowu Li

Southwest Hospital, China

研究点 (1)

Loading locations...

相似试验